352 related articles for article (PubMed ID: 22186319)
21. High prevalence of small LDL particles in non-insulin-dependent diabetic patients with nephropathy.
Hirano T; Naito H; Kurokawa M; Ebara T; Nagano S; Adachi M; Yoshino G
Atherosclerosis; 1996 Jun; 123(1-2):57-72. PubMed ID: 8782837
[TBL] [Abstract][Full Text] [Related]
22. Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.
Romero P; Salvat M; Fernández J; Baget M; Martinez I
J Diabetes Complications; 2007; 21(2):93-100. PubMed ID: 17331857
[TBL] [Abstract][Full Text] [Related]
23. Association of Serum Ferritin Levels with Microalbuminuria, Glycemic Control and Dyslipidemia.
Dubey K; Usman K; Chaudhary SC; Sawlani KK; Verma SK; Ali W
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443372
[TBL] [Abstract][Full Text] [Related]
24. Estimation of transforming growth factor-beta 1 as a marker of renal injury in type II diabetes mellitus.
Ibrahim S; Rashed L
Saudi Med J; 2007 Apr; 28(4):519-23. PubMed ID: 17457470
[TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy.
Nielsen FS; Voldsgaard AI; Gall MA; Rossing P; Hommel E; Andersen P; Dyerberg J; Parving HH
Diabetologia; 1993 May; 36(5):438-44. PubMed ID: 8314449
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of dyslipidemia associated with complications in diabetic patients: a nationwide study in Thailand.
Narindrarangkura P; Bosl W; Rangsin R; Hatthachote P
Lipids Health Dis; 2019 Apr; 18(1):90. PubMed ID: 30954084
[TBL] [Abstract][Full Text] [Related]
27. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
Kim NH; Kim KB; Kim DL; Kim SG; Choi KM; Baik SH; Choi DS; Kang YS; Han SY; Han KH; Ji YH; Cha DR
Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
[TBL] [Abstract][Full Text] [Related]
28. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
[TBL] [Abstract][Full Text] [Related]
29. Clinical Features and Microvascular Complications Risk Factors of Early-onset Type 2 Diabetes Mellitus.
Huang JX; Liao YF; Li YM
Curr Med Sci; 2019 Oct; 39(5):754-758. PubMed ID: 31612393
[TBL] [Abstract][Full Text] [Related]
30. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
Agardh CD; Agardh E; Torffvit O
Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
[TBL] [Abstract][Full Text] [Related]
31. The relationship between early diabetic nephropathy and control of plasma glucose in non-insulin-dependent diabetes mellitus. The effect of glycemic control on the development and progression of diabetic nephropathy in an 8-year follow-up study.
Kawazu S; Tomono S; Shimizu M; Kato N; Ohno T; Ishii C; Murata K; Watanabe T; Negishi K; Suzuki M
J Diabetes Complications; 1994; 8(1):13-7. PubMed ID: 8167381
[TBL] [Abstract][Full Text] [Related]
32. Study of Irisin Hormone Level in Type 2 Diabetic Patients and Patients with Diabetic Nephropathy.
Shelbaya S; Abu Shady MM; Nasr MS; Bekhet MM; Mageed YA; Abbas M
Curr Diabetes Rev; 2018; 14(5):481-486. PubMed ID: 28875825
[TBL] [Abstract][Full Text] [Related]
33. Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.
Lepira FB; M'Buyamba-Kabangu JR; Kayembe KP; Nseka MN
Cardiovasc J S Afr; 2005; 16(5):249-55. PubMed ID: 16307156
[TBL] [Abstract][Full Text] [Related]
34. Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative.
Russo GT; De Cosmo S; Viazzi F; Pacilli A; Ceriello A; Genovese S; Guida P; Giorda C; Cucinotta D; Pontremoli R; Fioretto P;
Diabetes Care; 2016 Dec; 39(12):2278-2287. PubMed ID: 27703024
[TBL] [Abstract][Full Text] [Related]
35. Levels of inflammatory markers and their correlation with dyslipidemia in diabetics.
Waheed P; Naveed AK; Farooq F
J Coll Physicians Surg Pak; 2009 Apr; 19(4):207-10. PubMed ID: 19356332
[TBL] [Abstract][Full Text] [Related]
36. [DIABETIC NEPHROPATHY AS A CAUSE OF CHRONIC KIDNEY DISEASE].
Kos I; Prkačin I
Acta Med Croatica; 2014 Dec; 68(4-5):375-81. PubMed ID: 26285470
[TBL] [Abstract][Full Text] [Related]
37. Nephropathy in patients with recently diagnosed type 2 diabetes mellitus in black Africans.
Wanjohi FW; Otieno FC; Ogola EN; Amayo EO
East Afr Med J; 2002 Aug; 79(8):399-404. PubMed ID: 12638839
[TBL] [Abstract][Full Text] [Related]
38. Relation of serum total sialic acid concentrations with diabetic complications and cardiovascular risk factors in Kuwaiti Type 2 diabetic patients.
Abdella N; Akanji AO; Mojiminiyi OA; Al Assoussi A; Moussa M
Diabetes Res Clin Pract; 2000 Sep; 50(1):65-72. PubMed ID: 10936670
[TBL] [Abstract][Full Text] [Related]
39. Prospective study of the impact of hypertension upon kidney function in diabetes mellitus.
Walker WG; Hermann J; Murphy RP; Russell RP
Nephron; 1990; 55 Suppl 1():21-6. PubMed ID: 2345589
[TBL] [Abstract][Full Text] [Related]
40. The positive association of branched-chain amino acids and metabolic dyslipidemia in Chinese Han population.
Yang P; Hu W; Fu Z; Sun L; Zhou Y; Gong Y; Yang T; Zhou H
Lipids Health Dis; 2016 Jul; 15():120. PubMed ID: 27457614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
